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tions of an aortic dissection can exceed 60%, depending
on the type and acuity of the dissection, as well as the
specific region that is ischemic.1,2 Reperfusion by means
of interventional radiologic methods has evolved into a
promising approach,3-6 but no large series have been
published. We therefore report the results of our initial 6
years’ experience with percutaneous balloon fenestra-
tion of the intimal flap and endovascular stenting.
Patients and methods
Definitions and statistical analysis. Between September
1992 and February 1998, 40 patients underwent percutaneous
treatment for peripheral ischemic complications of an acute
aortic dissection (complications appearing within 14 days of
the onset of symptoms). Patients underwent percutaneous
treatment for extremity, renal, or mesenteric ischemia associ-
A cute aortic dissection frequently causes life-threat-ening ischemia of distal end-organs. Historically,
the mortality rate in patients with ischemic complica-
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ated with an aortic dissection. Ischemia was determined by
clinical suspicion based on signs, symptoms, and laboratory
data in conjunction with imaging of the arterial supply to the
affected region. If any anatomic arterial abnormality related
to the aortic dissection involved the arterial supply to the
region suspected of being ischemic, the anatomic abnormali-
ty was considered to be responsible for the ischemia, and the
lesion was treated. Anatomic abnormalities discovered in the
arterial supply to an asymptomatic region were not treated.
For data analysis, involvement of either or both kidneys was
counted as one vascular bed, as was involvement of either or
both lower extremities.
Relevant data were collected from chart review for patients
treated before 1995. Beginning in 1995, data were collected
prospectively. Follow-up data were collected by telephone
interview with the patients or their families and were avail-
able in all patients. Cause of death was determined by review
of medical records or autopsy reports, if available.
Variability of clinically important fractions or rates is
expressed as ± 70% confidence levels (70% CL). Statistical
analysis was performed with the use of SPSS for Windows
(version 6.1, SPSS Inc, Chicago, Ill). Fifteen specific vari-
ables were evaluated as possible predictors of early mortality
and overall mortality. Ordinal variables included type of dis-
section (A versus B), renal ischemia, mesenteric ischemia,
extremity ischemia, ischemia of 1, 2, or 3 vascular beds, true
lumen collapse, sex, paraplegia/paraparesis, and stroke.
Continuous variables included date of procedure, age, num-
ber of stented vessels, and number of fenestrations. Early
mortality was defined as death within 30 days of the percuta-
neous procedure. Overall mortality was defined as all deaths
due to any cause. Multivariable regression was performed
with the use of the Cox proportional hazards model to ana-
lyze variables using a forward stepwise method. Variables
with a P value of .1 or less (to avoid a type II or b error given
the relatively small numbers of patients) in the univariable
screening were entered into the multivariable equation. The
magnitude of the clinical impact of predictive covariables on
early and overall mortality is reported as an indicator of rela-
tive risk, eb , but this can be strictly interpreted only for
dichotomous covariables.
Patients. The 40 patients (32 male and 8 female patients)
ranged in age from 16 to 86 years, with a mean of 53 years.
Ten had type A and 30 had type B dissections. Four of the
patients with an acute type B dissection had undergone surgi-
cal repair of a type A dissection 20 days to 8 years (median 2
years) before the percutaneous intervention; this represented
a new dissection superimposed on the chronic type A dissec-
tion. Two of the patients had Marfan syndrome, and 1 had
Ehlers-Danlos syndrome. Case histories of 18 of these
patients have been previously reported.4,7 Two patients had
initial resolution or improvement of ischemic symptoms fol-
Fig 1. Treatments of patients with acute aortic dissection from September 1992 through February 1998.
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lowed by symptom recurrence, and 2 patients had persistent
symptoms after the initial procedure. Each of these 4 patients
underwent a second percutaneous intervention 2, 7, 7, and 39
days (mean 14 days) after the initial one, for a total of 44 pro-
cedures.
Nine of the 10 patients with a type A dissection had under-
gone surgical graft replacement of the ascending aorta up to
14 days (median 1 day) before the percutaneous procedure.
The sole patient who did not have an operation had severe
heparin-induced thrombocytopenia with positive antibodies.
One of the 30 patients with a type B dissection underwent
graft replacement of the descending thoracic aorta immedi-
ately before the percutaneous procedure. During this same
period, 140 acute type A dissections and 24 acute type B dis-
sections were surgically repaired. The proportion of patients
with each type of dissection treated with surgery, percuta-
neous techniques, or both is shown in Fig 1.
Twenty patients had peripheral ischemic complications of
multiple organ systems. Thirty patients had renal, 22 had
lower extremity, 18 had mesenteric, and 1 had upper extrem-
ity ischemia. The distribution of ischemic symptoms is shown
in Table I. No patient was referred specifically for treatment
of stroke or spinal cord ischemia, although 4 patients who
had a stroke and 3 patients who had paraparesis or paraplegia
were treated for other ischemic complications.
Procedures. Only selected patients in whom there was
clinical suspicion of extremity, renal, or visceral ischemia
underwent arteriography; the diagnosis had been established
earlier, usually by means of transesophageal echocardiogra-
phy or computed tomography. When renal failure was pre-
sent, portions of the diagnostic arteriogram were performed
by the hand injection of carbon dioxide as the contrast agent
during digital subtraction arteriography. Intravascular ultra-
sound (IVUS) was used to define anatomic details of the dis-
section in many cases. In some patients hemodynamic pres-
sure measurements in both lumina were obtained to further
evaluate the significance of branch vessel involvement. Stent
placement and balloon fenestration of the intimal flap were
performed on a compassionate-use basis after informed con-
sent was obtained from the patient or his or her family.
Stent placement. Stents were placed into an aortic branch
artery if the vascular bed supplied by this vessel was com-
promised by extension of the dissection flap into the vessel,
narrowing or occluding its true lumen. In most instances,
attempts were made to restore flow to a branch vessel from
the true lumen of the aorta. However, if the vessel was ade-
quately perfused by the false lumen, it was not treated. In
some instances, stents were placed from the false lumen of
the aorta to restore flow to the true lumen of a branch vessel.
Aortic stents were placed to prop open the severely collapsed
true lumen and allow flow to reach distal branches supplied
exclusively by the aortic true lumen (Fig 2). Balloon-expand-
able Palmaz stents (Johnson & Johnson Interventional Sys-
tems, Warren, NJ) and self-expanding Wallstents (Schneider,
Plymouth, Minn) were placed into renal, iliac, superior
mesenteric, and brachiocephalic arteries, the celiac axis, and
into the aorta. For stent placement procedures, angiographic
sheaths ranging from 7F to 14F were used for arterial access.
Balloon fenestration. The technique of balloon fenestra-
tion has been previously described.4,7,8 Earlier in our experi-
ence, balloon fenestration was carried out in the descending
thoracic aorta, where IVUS guidance was helpful.
Subsequently, balloon fenestration was performed only at the
aortic bifurcation to treat lower extremity ischemia, because
more proximal fenestration in the thoracic aorta failed to con-
sistently provide adequate redirection of distal blood flow.
Because of the oblique angulation of the iliac arteries at the
aortic bifurcation, adjunctive use of IVUS was less useful.
Therefore all balloon fenestration procedures are currently
performed with only fluoroscopic guidance. 
To perform balloon fenestration (Fig 3), we percutaneously
catheterized both the true and false lumina. After creation of
the fenestration, flow through the fenestration was assessed
arteriographically. If flow to the ischemic lower extremity was
considered inadequate, a stent was placed in the iliac artery,
bridging the fenestration in the distal aortic flap. No stents
were placed across any fenestration that was performed above
the level of the abdominal aortic bifurcation.
In most cases, at the conclusion of both stent placement
and balloon fenestration procedures, the sheaths were
removed in the angiography suite and hemostasis at the punc-
ture site was obtained with manual compression.
Results
Of the 40 patients with a peripheral ischemic compli-
cation, 14 patients were treated with stenting of either
the true or false lumen combined with balloon fenes-
tration of the intimal flap, 24 with stenting alone, and 2
with fenestration alone. Many patients had stents
placed in multiple vessels. Twenty-two patients had
stents placed in a renal artery, 15 in an iliac artery, 6 in
the superior mesenteric artery, 1 in the celiac axis, 1 in
the brachiocephalic artery, and 12 in the aorta. In aor-
tic branch vessels, stents ranged from 5 mm in diame-
ter in a renal artery to 14 mm in diameter in an iliac
artery. In the aorta, stents ranged from 10 to 25 mm in
diameter. Balloon fenestration of the intimal flap was
performed in the descending thoracic aorta in 8
Table I. Distribution of ischemic complications in 40
patients with acute aortic dissection
Ischemic region No.
Renal/mesenteric/lower extremity 11
Renal/lower extremity 6
Renal/mesenteric 3
Renal 10
Lower extremity 5
Mesenteric 4
Upper extremity 1
Total 40
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Fig 2. Endovascular stent placement used to treat a 51-year-old man with mesenteric and renal ischemia related
to a type B dissection. Before percutaneous intervention the patient had resection of an ischemic right colon. A,
Digital subtraction arteriogram with the catheter in the aortic true lumen demonstrates a severely collapsed true
lumen that supplies the celiac axis. The origin of the superior mesenteric artery is occluded by an intimal flap. It
fills through collateral vessels from the gastroduodenal artery (large arrows) and then occludes a few centimeters
beyond the origin of a replaced right hepatic artery (small arrow). B, Arteriogram with injection of the false
lumen demonstrates supply to the right renal artery and both lower extremities. The left renal artery does not fill
from either the true or false lumen. C, Spot image in a lateral view demonstrates stents in the aorta, the proximal
superior mesenteric artery, and the left renal artery (arrow). D, Arteriogram in a lateral view with the catheter in
the aortic true lumen demonstrates filling of the superior mesenteric and left renal arteries.
A
B
C D
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patients, in the upper abdominal aorta in 3 patients, and
just above the level of the aortic bifurcation in 7
patients. Fenestration was performed at 2 separate lev-
els in 2 patients. Fenestration diameter ranged from 14
to 20 mm in the thoracic aorta, from 12 to 16 mm in the
upper abdominal aorta, and from 8 to 15 mm at the
A
B
C D
Fig 3. Balloon fenestration of the intimal flap used to treat an 80-year-old woman with left lower extremity
ischemia immediately after surgical repair of a type A dissection. A, Arteriogram with injection in the aortic false
lumen demonstrates flow to the right lower extremity but no flow to the left lower extremity. The true lumen was
severely collapsed, with no flow below the renal vessels. B, A large angioplasty balloon catheter is inflated in the
false lumen to use as a target. A curved metallic cannula is placed in the true lumen and pointed toward the inflat-
ed balloon in the opposite lumen. C, After a small needle is passed through the cannula into the opposite lumen,
a 5F angiographic catheter is advanced over the needle, and the needle is exchanged for a guide wire. An angio-
plasty balloon is advanced over the guide wire and inflated to dilate the fenestration in the intimal flap. D,
Arteriogram after creation of the fenestration demonstrates good flow from the false lumen through the fenestra-
tion to the left lower extremity.
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level of the aortic bifurcation. Of the 7 patients who had
a fenestration performed at the level of the aortic bifur-
cation, 3 had a stent placed through the fenestration
into the iliac artery.
Flow was successfully restored to the ischemic regions
in 37 of the 40 patients (93% ± 4%). In 3 patients revas-
cularization of an ischemic vascular bed could not be
successfully achieved. One patient had occlusion of the
superior mesenteric artery related to a type B dissection,
and this vessel could not be catheterized for stent place-
ment. The patient was treated with a renal artery stent
and surgical revascularization of the superior mesenteric
artery and left leg. Another patient with an acute type B
dissection was treated with placement of stents in the
aorta and bilateral iliac arteries for renal and leg
ischemia; however, the outflow from the right iliac
artery was obstructed by thrombus. While arrangements
were being made for the patient to undergo surgical
thrombectomy, the aortic false lumen ruptured and the
patient died 35 minutes after the procedure. The final
patient in whom percutaneous revascularization of an
ischemic region could not be accomplished had a type B
dissection with severe collapse of the true lumen and
mesenteric, renal, and lower extremity ischemia. She
was treated with an aortic stent graft and bilateral renal
artery stents, followed by resection of most of the
infarcted small bowel and surgical removal of the large
groin sheaths. Postoperatively, the right leg was cold,
with no popliteal pulse. No further heroic measures
were deemed appropriate after discussion with the fam-
ily. She underwent right leg amputation but died of mul-
tiorgan failure 6 days after the percutaneous procedure.
An additional 2 patients required early resection of
infarcted bowel but died of multiorgan failure 21 and 24
days after the percutaneous procedure. Two patients
required delayed bowel resection (resection of ischemic
sigmoid colon in 1 and resection of an ischemic small
bowel stricture in the other, both 1 month later), and
these patients have survived for 39 and 68 months,
respectively. Seven patients (3 of whom had required
early bowel resection and 1, delayed bowel resection)
required early dialysis; five died within 30 days, and 2
were no longer dialysis dependent at 39 and 59 months.
No additional patients required early amputation or sur-
gical revascularization for limb ischemia.
Ten of the 40 patients (25% ± 7%) died within 30
days of the percutaneous procedure, all while still in the
hospital. Causes of death included multiorgan failure in
6, rupture of the false lumen of the descending thoracic
aorta in 2, right heart failure from extension of the dis-
section into the right coronary artery in the 1 patient
with a type A dissection who was not operated on, and
Table II. Outcomes of percutaneous treatment by distribution of ischemic complications in 40 patients with acute
aortic dissection
Outcomes
Type Bowel resection Early Early Complication Death Mean follow-up 
Ischemic region N A B Early Delayed dialysis amputation Major Minor Early Late Alive (mo)
Renal/mesenteric/ 11 1 10 2 1 4 1 1 2 6 1 4 15.5
lower extremity
Renal/lower extremity 6 2 4 1 1 1 4 29.6
Renal/mesenteric 3 3 1 1 1 1 2 21.5
Renal 10 3 7 2 1 1 1 2 7 19.8
Lower extremity 5 2 3 5 40.2
Mesenteric 4 1 3 1 1 1 3 52.0
Upper extremity 1 1 1 1
Total 40 10 30 3 2 7 1 3 6 10 5 25
Table III. Complications in patients treated percuta-
neously for peripheral ischemic complications of
acute aortic dissection
Complication N %
Stent misplacement 3 7.5
Recaptured and deployed 1
Removed percutaneously 1
Removed surgically from 1
femoral artery
Femoral artery pseudoaneurysm 2 5.0
Ultrasound-guided compression 1
Surgical repair 1
Transient ischemic attack 1 2.5
Thrombosis of renal artery stent 1 2.5
with renal atrophy
Posterior tibial artery embolus 1 2.5
with transmetatarsal amputation
Infection 1 2.5
Total 9 22.5
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complications related to surgical repair of a type A dis-
section in 1. The only statistically significant predictors
of early mortality were ischemia of 3 vascular beds (eb
= 3.70) and later procedure date (eb = 1.68) (P = .008).
Five patients have died beyond the first 30 days after the
percutaneous procedure, 1 of rupture of the false lumen
of the descending thoracic aorta at 76 days, 1 of squa-
mous cell cancer at 20 months, and 1 of congestive heart
failure after 21 months. Two patients died sudden, unex-
plained deaths at 13 and 24 months and did not have an
autopsy. The remaining 25 patients were alive at a mean
follow-up time of 29 months. The variables found to be
significant, independent predictors of overall death
according to multivariable analysis were ischemia of 3
vascular beds (eb = 4.23) and older age (eb = 1.04)(P =
.006). The clinical outcomes and follow-up times in
those still alive are shown in Table II, categorized by
distribution of ischemic complications.
Complications. Nine patients had procedure-related
complications, which are detailed in Table III. Of these,
only 3 are considered major because they were associ-
ated with important clinical consequences: One patient
had thrombosis of a stented renal artery that eventually
caused atrophy of a kidney, another required a trans-
metatarsal amputation because of an embolus to the
posterior tibial artery, and the third had sepsis with
blood cultures positive for Staphylococcus aureus after
placement of a renal artery stent (no other source of
infection could be identified). This last patient was
treated with antibiotics until his death from aortic rup-
ture 2.5 months later.
Discussion 
Aortic dissection is complicated by ischemia of
peripheral vascular beds in approximately 30% of
patients.1,2,9,10 Historically, patients with ischemic com-
plications have had markedly increased mortality rates,
regardless of medical or surgical treatment.1,2,10,11
Surgical repair of the aortic dissection often resolves the
peripheral ischemia.2,12 However, if laparotomy for sus-
pected bowel ischemia or infarction is subsequently
required after repair of the dissection, the mortality rate
rises to 80%.2 Until recently, good alternatives to direct
surgical revascularization have not existed for patients
with acute type A dissections in whom peripheral
ischemia persists after graft replacement of the ascend-
ing thoracic aortic. Similarly, patients who would oth-
erwise be treated medically for a type B dissection have
required surgical revascularization if peripheral
ischemic complications arise. The evolution of percuta-
neous techniques provides the potential opportunity to
reperfuse ischemic regions without the morbidity asso-
ciated with a major vascular surgical procedure.
In the overall Stanford surgical experience of patients
with aortic dissections, renal or visceral ischemia was an
independent determinant of higher operative mortality
risk.10 Similarly, focusing on just those patients under-
going thoracic aortic replacement who had peripheral
vascular complications of their dissection, impaired
renal perfusion was a significant, independent predictor
of operative death, whereas stroke, paraplegia, and
mesenteric or extremity ischemia were not.2 In this cur-
rent (smaller) study, ischemia of any one specific vascu-
lar bed was not linked with a higher likelihood of death;
rather, in these 40 patients treated with percutaneous
methods, ischemia of 3 vascular beds was the only sig-
nificant patient-related risk factor for early mortality
(and was associated with a nearly 4-fold increase in risk
[eb = 3.70]). The association between later procedure
date and higher early mortality was initially thought to
be related to treatment of an increasing number of
patients with more severe or potentially irreversible
peripheral ischemic complications as our experience
with these techniques progressed. Close examination of
the data, however, revealed 1 year (1996) during which
4 of the 5 treated patients died within 30 days of the pro-
cedure, likely skewing the statistics.
It is difficult to make strict comparisons between the
surgically and percutaneously treated patients with
peripheral vascular complications because the patient
populations and eras of treatment differ substantially.
Type A dissections were present in only 25% of the
percutaneously treated patients in our series (and all
save one had already undergone surgical repair of the
ascending aorta), compared with 55%1 to 73%2 of
patients in the earlier surgical series. When surgically
treated patients with type B dissections who have
peripheral vascular complications similar to those in
this current series are considered, however, the 25% ±
7% early death rate after percutaneous treatment com-
pares favorably with the earlier reported operative mor-
tality rate of 64% for patients with acute type B dissec-
tions.2 Again, strict comparisons between these series
are not possible.
Surgical fenestration of the aortic intimal flap to
relieve peripheral vascular ischemic complications has
recently resurged as a viable therapeutic approach in
the view of some surgical groups and is fairly well tol-
erated by most patients. Small series of patients who
underwent surgical fenestration of the abdominal aorta
either after graft replacement of the thoracic aorta or as
an isolated primary therapeutic procedure have shown
that it can be effective in relieving lower extremity, vis-
ceral, and renal ischemia, with early mortality rates
ranging from 0% to 21%.13,14 As was the case in this
report after percutaneous treatment, some patients
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also required amputation13 or bowel resection14 despite
restoration of branch vessel perfusion. Surgical fenes-
tration is reported to improve symptoms of spinal cord
ischemia rarely, something that was not observed in our
experience after percutaneous interventions.
The severity and the duration of visceral ischemia
before intervention undoubtedly have an important
impact on outcomes and patient survival. By the time
the clinical diagnosis of renal or mesenteric ischemia
can be made with confidence, irreversible gut infarction
has often already occurred. The catastrophic conse-
quences associated with delayed diagnosis of ischemic
intra-abdominal complications resulting from acute aor-
tic dissection underscore the need for a high level of
clinical suspicion, close monitoring, and a low threshold
for performing diagnostic studies to assess the arterial
perfusion status in patients with acute aortic dissection.
The occurrence of procedure-related complications
in 9 of the 40 patients (23%) treated percutaneously is
relatively high. Only 3 of these complications (8%),
however, had long-term clinical sequelae. The frequen-
cy with which stents were misplaced was related to dif-
ficulty in choosing the appropriate stent size. The opti-
mal stent diameter required in a dissected vessel is
poorly characterized. Arbitrary oversizing may increase
the risk of rupture in an already weakened artery; how-
ever, impaired elastic recoil of the arterial wall may not
secure a stent expanded to less than the transverse
diameter of the combined lumina.
Although the potential for successful reperfusion of
ischemic vascular beds using percutaneous techniques
has been demonstrated in patients with acute aortic dis-
sections, debate continues concerning the most appro-
priate timing for surgical repair of the thoracic aorta and
percutaneous treatment of peripheral ischemic vascular
complications. Percutaneous and medical treatment of
branch vessel ischemic complications with delayed sur-
gical repair of the ascending aorta in patients with acute
type A dissections has been advocated by the University
of Michigan surgical group, in an attempt to decrease
the very high surgical mortality rates seen earlier in sim-
ilar patients in their center.6 Immediate percutaneous
treatment of jeopardized downstream end-organs, fol-
lowed without delay by surgical graft replacement of the
thoracic aorta, has been suggested as one possible
approach to prevent additional (and possibly irre-
versible) damage of ischemic end-organs during the sur-
gical procedures on the thoracic aorta.15 Nine of the 10
patients with an acute type A dissection in this report
had just undergone surgical repair of the thoracic aorta
before percutaneous intervention. Inasmuch as mortali-
ty risk in untreated patients with acute aortic dissections
approximates 1% per hour (with death usually being
due to aortic rupture causing pericardial tamponade or
exsanguination into the chest or acute aortic valvular
insufficiency),16 we continue to believe that immediate
surgical repair of the ascending aorta is the most pru-
dent course for almost all patients with acute type A aor-
tic dissections. Repair of the thoracic aorta usually
relieves the peripheral ischemia, but close postoperative
surveillance is crucial to identify quickly any persistent
or new distal ischemia or “malperfusion” such that per-
cutaneous treatment may be undertaken expeditiously.
A smaller proportion of our patients with acute type
B dissections had prior surgical repair of the thoracic
aorta before percutaneous intervention. In untreated
patients with acute type B dissection, early death is
most frequently due to pleural rupture or peripheral
ischemic complications. The likelihood of aortic rup-
ture can be markedly reduced with appropriate medical
treatment, and the peripheral ischemic complications
can be treated with percutaneous techniques. If suc-
cessful, this approach reduces the need for surgical
repair of the descending thoracic aorta through a left
thoracotomy, which carries substantial morbidity.
This study has several limitations. Our definitions of
peripheral ischemia may have prompted percutaneous
treatment of vascular beds that were not actually in crit-
ical jeopardy. This aggressive approach in treating
potentially ischemic regions is consistent with our
desire to avoid any delay in treatment, which may por-
tend irreversible damage. Our follow-up data are only
subjective, retrospective, and based on patient recollec-
tion. More information could have been gleaned from
this study if we had had objective laboratory or imag-
ing data or both for confirmation of prolonged patency
of treated arteries and relief of ischemia. Finally, the
number of patients is relatively small, and the available
follow-up is relatively short; additional evaluation out
to 5 to 10 years in larger numbers of patients will be
necessary before the real therapeutic effectiveness of
percutaneous fenestration and stenting in patients with
peripheral ischemic complications resulting from acute
aortic dissections can be known with certainty.
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Discussion
Dr Scot H. Merrick (San Francisco, Calif). I thank Dr
Slonim and her colleagues for updating us on the Stanford
experience. This experience is the largest in the world and is
very impressive.
The traditional teaching for aortic dissection is that acute
type A dissections should be treated surgically, whereas acute
type B dissections can be either operated on or observed
depending on the patient and perhaps the surgeon’s philoso-
phy. In most cases those patients do reasonably well. The
patients that you have just discussed are the most difficult to
treat and have the highest mortality. In fact, treatment options
have really plateaued over the past decade in this population;
perhaps your strategy at this point is opening the door a bit for
new treatment therapies.
I do have several questions. The first relates to the outcome
of organ ischemia. The data on mortality are useful, but do
you have any objective data, clinical or biochemical, that
would indicate what happens to the organ ischemia before
and after the procedure?
Dr Slonim. I do not have objective data; I have subjective
clinical data. We have monitored weight gain and loss, as
well as gastrointestinal symptoms, in patients with mesen-
teric ischemia. In patients with renal ischemia, we know
whether they have begun using dialysis, and we know how
many medications it takes to control their blood pressure. A
few patients with renal ischemia have had nuclear medicine
renal scans to evaluate renal perfusion. Overall, however,
objective follow-up information is minimal. The follow-up
we do have suggests that patients who survive the acute cri-
sis are likely to do well in the long term.
Dr Merrick. I imagine these procedures take time in your
interventional suite and a certain amount of contrast material
is delivered. Did you find any correlation between the length
of the procedure and/or the amount of contrast material deliv-
ered and the morbidity of the procedure?
Dr Slonim. We have not evaluated the length of the proce-
dure or the amount of contrast material used during the proce-
dure. In terms of contrast load, in patients in whom we suspect
renal ischemia, we perform portions of the diagnostic study
with carbon dioxide arteriography with digital subtraction.
Also, if we have a high-quality computed tomographic scan
beforehand, we can limit the amount of contrast medium used
during arteriography. Obviously the computed tomographic
scan involves a contrast load, but the benefit of knowing the
anatomy of the dissection before we begin allows us to limit
the time and contrast material for the interventional procedure.
Alternatively, intravascular ultrasound can be used to define
the anatomy of the dissection before we intervene.
Dr Merrick. I have a theoretical question regarding the
patient whose angiogram you presented. If you have a
patient with a type B dissection with a severe collapse of the
true lumen and you stent the aorta, the proximal entrance
point is still open, and yet you may be occluding the exit
points down in the distal aorta. Do you think that could
result, either immediately or over the long term, in an
increased risk of rupture, extension of the dissection, or
aneurysm formation?
Dr Slonim. I do not think we occlude the re-entry tear.
There may be re-entry tears at multiple levels along the
length of the aorta, related to the intercostal and visceral
arteries. The stents we use have fairly large interstices. In
fact, we have stented over the origins of visceral vessels that
maintain flow through the stents, so I do not think that we
occlude re-entry tears.
We do not know, however, what happens in the long term
to patients who are treated with aortic stents. It is true that we
are leaving the entry tear open, and the false lumen does stay
patent. It seems reasonable that patients whose blood pres-
sure is inadequately controlled would be at risk of aneurys-
mal enlargement and potential rupture of the false lumen.
Dr Merrick. Of the 11 patients with acute type A dissec-
tion, 2 were treated percutaneously first. Does that represent
a change in either Dr Miller’s or Dr Mitchell’s philosophy on
treating type A dissection? 
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Dr Slonim. One of those patients had a tiny dissection flap
in the arch, just proximal to the left subclavian artery, with no
involvement of the ascending aorta. The other patient had a
heparin-induced antibody, and therefore surgery was with-
held. I do not believe that the aggressive surgical approach to
patients with a type A dissection at Stanford has been altered.
Dr Merrick. I am relieved. Finally, do you prescribe long-
term anticoagulation for those patients with stents?
Dr Slonim. No, we do not. In rare instances we have
noticed clot forming during the procedure and have used
heparin or urokinase. However, we are usually dealing with
an acutely dissected aorta, and we are reluctant to use antico-
agulation. In general, stents placed in a patient with an aortic
dissection are dilated larger than expected for nondissected
vessels, and the amount of flow through them is sufficient to
keep them patent without anticoagulation. One renal stent
thrombosed immediately on deployment. Otherwise, we have
not had any stents thrombose.
Dr Merrick. I look forward to the long-term imaging stud-
ies on these patients.
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